Lutronic saw the highest growth of 0.49% in patent filings in June and 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Lutronic’s patent filings and grants. Buy the databook here.
Lutronic has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 67% filings and 67% grants. The United States(US), European Patent Office(EPO), and South Korea(KR) patent Office are among the top ten patent offices where Lutronic is filings its patents. Among the top granted patent authorities, Lutronic has 67% of its grants in United States(US) and 33% in South Korea(KR).
Recens Medical and Boston Scientific could be the strongest competitors for Lutronic
In terms of grant share, Lutronic stands in third position among its competitors. Recens Medical and Boston Scientific secured the top positions according to recent patent publication data.
Patents related to healthtech lead Lutronic's portfolio
Lutronic has the highest number of patents in healthtech. For healthtech, nearly 100% of patents were filed and no patents were granted in Q2 2024.
General surgery devices related patents lead Lutronic portfolio followed by laser transmitter, and cosmetics & toiletries
Lutronic has highest number of patents in general surgery devices followed by laser transmitter, cosmetics & toiletries, skincare.
For comprehensive analysis of Lutronic's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.